638217-07-9

Basic information

• Product Name: 6-Methoxy-N,2-diMethylbenzofuran-3-carboxaMide
• Synonyms: 6-Methoxy-N,2-diMethylbenzofuran-3-carboxaMide;6-methoxy-N,2-dimethyl-1-benzofuran-3-carboxamide;6-METHOXY-N,2-DIMETHYLBENZOFURAN-3-CARBOXAMIDE(WXG01734)
• CAS NO: 638217-07-9
• Molecular Formula: C12H13NO3
• Molecular Weight: 219.23652
• Mol File: 638217-07-9.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 6-Methoxy-N,2-diMethylbenzofuran-3-carboxaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Methoxy-N,2-diMethylbenzofuran-3-carboxaMide(638217-07-9)
• EPA Substance Registry System: 6-Methoxy-N,2-diMethylbenzofuran-3-carboxaMide(638217-07-9)

Safety Data

• Hazardous Substances Data: 638217-07-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
MDB is used as a research compound for its pharmacological activities, including anti-inflammatory, anticancer, and neuroprotective properties. It is studied for its potential use in the treatment of various diseases and conditions.
Used in Drug Development:
MDB is used as a building block in the synthesis of other chemical compounds, and may have potential applications in drug development and medicinal chemistry.
Used in Chemical Synthesis:
MDB is used as a chemical compound in the synthesis of other compounds, contributing to the development of new drugs and pharmaceuticals.

Upstream product

• 854514-66-2 C₁₁H₉ClO₃ 
• 74-89-5 methylamine 
• 29040-48-0 6-methoxy-2-methylbenzofuran 
• 638217-03-5 methyl 6-hydroxy-2-methylbenzo[b]thiophene-3-carboxylate 
• 103986-33-0 6-methoxy-2-methyl-benzofuran-3-carboxylic acid 

Downstream Products

• 638217-08-0 6-hydroxy-2-methylbenzofuran-3-carboxylic acid methylamide 

Relevant articles and documents

METHODS OF PREPARING A VEGF-R INHIBITOR

The present invention relates to methods for preparing a compound of formula (7), which is useful as a modulator and/or inhibitor of protein kinases. The present invention also relates to intermediate compounds useful in the preparation of a compound of f

NOVEL QUINOLINE DERIVATIVES

The invention relates to compounds represented by Formula (I): and to pharmaceutically acceptable salts or solvates of said compounds, wherein each of A, R3-8, X3, X5, m, and n are defined herein. The invention also relates to pharmaceutical compositions containing the compounds of Formula (I) and to methods of treating hyperproliferative disorders in a mammal by administering compounds of Formula (I).

Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use

The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.

BENZOFUSED HETEROARYL AMIDE DERIVATIVES OF THIENOPYRIDINES USEFUL AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME, AND METHODS FOR THEIR USE

The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.